Temocapril (also known as temocaprilum [Latin]; brand name Acecol) is an ACE inhibitor.

It is administered as inactive prodrug, then converted to its active metabolite, temocaprilat.

[1] It was patented in 1984 and approved for medical use in 1994.

This drug article relating to the cardiovascular system is a stub.

You can help Wikipedia by expanding it.This stereochemistry article is a stub.